If your browser is equipped with a CML aware plug-in, then the CML will be
processed to render a 2D or 3D model of the molecular
structure.
If your browser is NOT CML aware, then you can use the "Jumbo3" program
included on the cdrom, to render the CML file.
1-(2, 5-Dichlorophenyl)-3-(hexahydro-1H-azepin-1-yl)urea | N(C(=O)NN1CCCCCC1)c2cc(Cl)ccc2Cl |
1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea | S(=O)(=O)(NC(=O)NN1CCCCCC1)c2ccc(C)cc2 |
1-(p-Cyanophenyl)-3-(hexahydro-1H-azepin-1-yl)urea | N(C(=O)NN1CCCCCC1)c2ccc(C#N)cc2 |
1-Piperazineethanol, 4-(3-(5H-dibenz(b, f)azepin-5-yl)propyl)- | C(CCN1CCN(CCO)CC1)N2c3ccccc3C=Cc4ccccc24 |
1H-Azepin-1-amine, N-((4-chloro-3-nitrophenyl)methylene)hexahydro- | [N+](=O)([O-])c1cc(ccc1Cl)C=NN2CCCCCC2 |
1H-Azepin-1-amine, hexahydro- | NN1CCCCCC1 |
1H-Azepin-1-amine__N-((4-chloro-3-nitrophenyl)methylene)hexahydro- | [N+](=O)([O-])c1cc(ccc1Cl)C=NN2CCCCCC2 |
1H-Azepin-1-amine__hexahydro- | NN1CCCCCC1 |
2H-Azepin-2-one, 1-acetylhexahydro- | C(C)(=O)N1CCCCCC1=O |
2H-Azepin-2-one, 3,3-dibromohexahydro- | BrC1(Br)CCCCNC1=O |
2H-Azepin-2-one, 3,3-dichlorohexahydro- | ClC1(Cl)CCCCNC1=O |
2H-Azepin-2-one, hexahydro- | O=C1CCCCCN1 |
2H-Azepin-2-one, hexahydro-1-(2-pyridinyl)- | O=C1CCCCCN1c2ccccn2 |
2H-Azepin-2-one, hexahydro-1-(2-pyridyl)- | O=C1CCCCCN1c2ccccn2 |
2H-Azepin-2-one, hexahydro-1-methyl- | O=C1CCCCCN1C |
2H-Azepin-2-one, hexahydro-7-methyl- | CC1CCCCC(=O)N1 |
2H-Azepin-2-one, hexahydro-N-methyl- | O=C1CCCCCN1C |
2H-Azepin-2-one__1-acetylhexahydro- | C(C)(=O)N1CCCCCC1=O |
2H-Azepin-2-one__3_3-dibromohexahydro- | BrC1(Br)CCCCNC1=O |
2H-Azepin-2-one__3_3-dichlorohexahydro- | ClC1(Cl)CCCCNC1=O |
2H-Azepin-2-one__hexahydro-1-(2-pyridinyl)- | O=C1CCCCCN1c2ccccn2 |
2H-Azepin-2-one__hexahydro-7-methyl- | CC1CCCCC(=O)N1 |
2H-Azepin-2-one__hexahydro-N-methyl- | O=C1CCCCCN1C |
2H-Azepin-7-one, hexahydro- | O=C1CCCCCN1 |
4-(3-(5H-Dibenz(b,f)azepin-5-yl)propyl)-1-piperazineethanol | C(CCN1CCN(CCO)CC1)N2c3ccccc3C=Cc4ccccc24 |
Hexahydro-1-(2-pyridyl)-2H-azepin-2-one | O=C1CCCCCN1c2ccccn2 |
Hexahydro-2H-azepin-2-one | O=C1CCCCCN1 |
Phenol, o-(N-(hexahydro-1H-azepin-1-yl)formimidoyl)- | C(=NN1CCCCCC1)c2ccccc2O |
Phenol, o-(N-(hexahydro-1H-azepin-1-yl)forminidoyl)- | C(=NN1CCCCCC1)c2ccccc2O |
Phenol__o-(N-(hexahydro-1H-azepin-1-yl)formimidoyl)- | C(=NN1CCCCCC1)c2ccccc2O |
Phosphine oxide, (bis(1-aziridinyl)(hexahydro-1H-azepin-1-yl)- | P(=O)(N1CC1)(N2CC2)N3CCCCCC3 |
Phosphine oxide, bis(1-aziridinyl)(hexahydro-1H-azepin-1-yl)- | P(=O)(N1CC1)(N2CC2)N3CCCCCC3 |
Phosphine oxide, diaziridinyl(hexahydro-1H-azepin-1-yl)- | P(=O)(N1CC1)(N2CC2)N3CCCCCC3 |
Phosphine sulfide, bis(1-aziridinyl)(hexahydro-1H-azepin-1-yl)- | P(=S)(N1CC1)(N2CC2)N3CCCCCC3 |
Phosphine_oxide__(bis(1-aziridinyl)(hexahydro-1H-azepin-1-yl)- | P(=O)(N1CC1)(N2CC2)N3CCCCCC3 |
Phosphine_oxide__bis(1-aziridinyl)(hexahydro-1H-azepin-1-yl)- | P(=O)(N1CC1)(N2CC2)N3CCCCCC3 |
Phosphine_sulfide__bis(1-aziridinyl)(hexahydro-1H-azepin-1-yl)- | P(=S)(N1CC1)(N2CC2)N3CCCCCC3 |
Rifamycin, 4-O-(2-(hexahydro-1H-azepin-1-yl)-2-oxoethyl)- | O(CC(=O)N1CCCCCC1)c2cc3NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)C=COC4(C)Oc5c(C)c(O)c(c3O)c2c5C4=O |
Urea, 1-((p-chlorophenyl)sulfonyl)-3-(hexahydro-1H-azepin-1-yl)- | S(=O)(=O)(NC(=O)NN1CCCCCC1)c2ccc(Cl)cc2 |
Urea, 1-(2,5-dichlorophenyl)-3-(hexahydro-1H-azepin-1-yl)- | N(C(=O)NN1CCCCCC1)c2cc(Cl)ccc2Cl |
Urea, 1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)- | S(=O)(=O)(NC(=O)NN1CCCCCC1)c2ccc(C)cc2 |
Urea, 1-(p-cyanophenyl)-3-(hexahydro-1H-azepin-1-yl)- | N(C(=O)NN1CCCCCC1)c2ccc(C#N)cc2 |
Urea, N-(2,5-dichlorophenyl)-N'-(hexahydro-1H-azepin-1-yl)- | N(C(=O)NN1CCCCCC1)c2cc(Cl)ccc2Cl |
Urea, N-(4-cyanophenyl)-N'-(hexahydro-1H-azepin-1-yl)- | N(C(=O)NN1CCCCCC1)c2ccc(C#N)cc2 |
Urea__N-(2_5-dichlorophenyl)-N'-(hexahydro-1H-azepin-1-yl)- | N(C(=O)NN1CCCCCC1)c2cc(Cl)ccc2Cl |
Urea__N-(4-cyanophenyl)-N'-(hexahydro-1H-azepin-1-yl)- | N(C(=O)NN1CCCCCC1)c2ccc(C#N)cc2 |
o-(N-(Hexahydro-1H-azepin-1-yl)forminidoyl)phenol | C(=NN1CCCCCC1)c2ccccc2O |